Johnson & Johnson Deeply Regrets Skipping Last Protection Payment To The Trump Regime

EFFIE BATEMAN | Lifestyle | Contact

A pharmaceutical company formerly owned by Johnson & Johnson is reportedly sorely regretting missing their latest ‘protection money’ payments to the Trump administration, after US President Donald Trump today announced a supposed link between Tylenol (acetaminophen) use during pregnancy, and autism.

Despite numerous studies disputing such a connection, Trump has gone on record saying, “They are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary,” effectively advising pregnant women to avoid Tylenol at all costs.

Where associations exist, the increase in risk is tiny  – an estimated 0.09% higher risk of autism by age 10 in children whose mothers used acetaminophen versus those who did not.

Much stronger studies, including a large Swedish study of 2.5 million children, found no evidence that acetaminophen causes autism, ADHD, or intellectual disability.

That study used sibling comparisons, where one sibling was exposed in utero and the other was not, controlling for family-level factors.

It is unclear whether Tylenol itself could be responsible for the small observed risk, or if the underlying conditions it treats – such as fever, infection, or pain.

Meanwhile, Kenvue Inc., the company now responsible for Tylenol is reportedly kicking itself for missing payments to the so-called Trump protection racket.

Rumours of a Tylenol–autism announcement had been circulating for months, and the company’s share price fell from $24 to $17 over the past year.

It remains unknown how many US politicians have purchased shares this week, and whether the Trump administration will eventually discover that Tylenol is, in fact, perfectly safe for pregnant women.

More to come.